- Home
- JCI vs PFE Comparison
JCI vs PFE Comparison
Compare JCI & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JCI | PFE |
|---|---|---|
| Founded | 1885 | 1849 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.7B | 147.6B |
| IPO Year | 2007 | 2013 |
Fundamental Metrics
Financial Performance| Metric | JCI | PFE |
|---|---|---|
| Price | $142.99 | $27.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | ★ $134.60 | $29.29 |
| AVG Volume (30 Days) | 3.5M | ★ 32.8M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | 1.13% | ★ 6.55% |
| EPS Growth | ★ 99.60 | N/A |
| EPS | ★ 1.86 | 0.43 |
| Revenue | $9,902,000,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $7.61 | N/A |
| Revenue Next Year | $6.57 | N/A |
| P/E Ratio | $76.88 | ★ $65.06 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $103.82 | $23.59 |
| 52 Week High | $157.06 | $28.75 |
Technical Indicators
Market Signals| Indicator | JCI | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 44.65 | 69.03 |
| Support Level | $135.98 | $24.90 |
| Resistance Level | $146.58 | $28.75 |
| Average True Range (ATR) | 3.30 | 0.52 |
| MACD | -1.27 | 0.13 |
| Stochastic Oscillator | 21.20 | 81.71 |
Price Performance
Historical ComparisonAbout JCI Johnson Controls International plc
Following Johnson Controls' divestiture of its residential and light commercial HVAC businesses to Bosch in 2025, nearly all of its revenue comes from commercial HVAC (60%) and fire and security products and services (40%). A 2016 merger joined Johnson Controls' HVAC and Tyco's fire and security businesses with the premise that there is synergy in offering a broader variety of automation products and solutions to commercial buildings. We estimate Johnson Controls' pro forma revenue mix will be one-third products, one-third installation, and one-third services.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.